The new Resident Evil reboot has shattered the franchise’s opening‑week record, pulling in $60 million in the United States and $48.3 million internationally for a global total of $108.3 million. The figure far exceeds the $40‑$50 million range that analysts had projected and eclipses the $26 million debut of Resident Evil: Afterlife in 2010, the previous high point in the series.
Record‑Breaking Opening
Sony’s $75 million investment has paid off immediately. The film’s domestic performance is the largest in the 24‑year‑old horror saga, and the worldwide start of $108.3 million places it among the top‑grossing entries for a rebooted franchise. The success comes after Sony’s last attempt, Resident Evil: Welcome to Raccoon City (2021), which earned only $42 million worldwide against a $25 million budget.
Audience Reception
Word‑of‑mouth and critical acclaim have been key drivers. Resident Evil holds a 96 % approval rating on Rotten Tomatoes and earned a “B+” grade on CinemaScore exit polls, a rare combination for a horror film. “Putting Zach Cregger in charge of a major franchise like ‘Resident Evil’ [made] something familiar feel fresh and original again,” says analyst Paul Dergarabedian, Rentrak’s head of marketplace trends. The director’s track record—Barbarian ($270 million worldwide on a $38 million budget) and Weapons ($43 million domestic, $270 million worldwide)—has built a reputation for turning modest projects into box‑office hits.
Franchise Context
The 1996 video‑game property was first adapted for cinema in 2002, with Milla Jovovich starring as Alice. The original series of films opened in the $20 million range, while Afterlife remains the highest‑grossing installment at $300 million globally. Cregger’s new film reunites him with Weapons actor Austin Abrams, who plays a medical courier battling a viral outbreak in Raccoon City.
Competitive Landscape
Resident Evil dominated the domestic box office this weekend, leaving Practical Magic 2 in second place with $12 million and Spider‑Man: Brand New Day in third with $6.5 million. The horror title’s performance has helped counter the expected lull between the summer and holiday seasons. “The fact that ‘Resident Evil’ has over performed to this degree is huge for the fall box office,” says Dergarabedian.
Market analysis
Sony’s strategic choice to invest $75 million in a franchise with a proven fan base has yielded a strong return on investment. The film’s opening suggests a renewed appetite for high‑concept horror, especially among Gen Z audiences, who “love horror movies.” A robust domestic start translates into higher ancillary revenues—home‑video sales, streaming rights, and merchandise—potentially offsetting the studio’s marketing spend. The success also positions Sony favorably against competitors such as Warner Bros. and Universal, who are releasing their own tentpole titles in the coming weeks.
The strong opening may influence future franchise decisions. Studios may be more inclined to green‑light reboots of established IPs if they can secure a director with a track record of delivering profitable, critically well‑received films. For investors, the Resident Evil performance underscores the value of intellectual property that can be revitalized with fresh creative talent.
Looking Ahead
Sony will likely extend the film’s theatrical run, capitalizing on the momentum from positive reviews and audience scores. The studio may also explore additional revenue streams, such as tie‑in media and expanded merchandise, to build on the film’s success. As the fall slate expands with releases like Paramount’s Heart of the Beast and A24’s Primetime, Resident Evil sets a high bar for what a horror reboot can achieve in the current market.
The film’s performance demonstrates that a well‑executed reboot can not only revive a dormant franchise but also generate substantial upside for the studio and its stakeholders.